Stellantis Turnaround Plan Prediction Market Regulation Oura IPO Filing Among Key Investor Items in CNBC Morning Squawk Retail Spending Surge Continues Amid Economic Uncertainty Reports National Retail Federation US 10Year Bond Yield The Key Indicator Shaping Borrowing Costs Stock Valuations and Global Capital Flows Burberry Shares Surge on Reports of Potential Moncler Acquisition Bid Vanguard Warns Common Retirement Savings Mistake Could Cost Americans Up to 120000 Airtel Defends Priority Postpaid Plan Before DoT Panel Cites Regulatory Framework for Network Slicing DRCT Q1 2026 Earnings EPS Beats Estimates Despite Negative Results Lyft Q1 2026 Earnings EPS Misses Estimates Stock Rises on Strategic Progress TRINI Q1 2026 Earnings EPS Beats Estimates as Net Investment Income Holds Steady RMR Q1 2026 Earnings EPS Misses Estimates Amid Flat Revenue Disclosure VLYPN Q1 2026 Earnings Preferred Stock EPS Beats Estimates by 507 ESPR Q1 2026 Earnings A BottomLine Miss as Investors Look for Growth Catalysts My Size Inc MYSZ Edges Higher as Price Holds Near Support Level Maui Land Pineapple MLP Edges Higher as Support Holds Near 162 BWNB Senior Notes Hold Steady Near Par as Support and Resistance Levels Tighten GCI Liberty GLIBK Under Pressure as Shares Slide Over 3 Cemex CX Edges Higher with Modest Gains Key Levels in Focus HFCL Shares Surge 140 in Two Months on Strong Earnings and Export Orders Design Therapeutics Inc DSGN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Gene Therapy Pipeline Chiron Real Estate Inc XRN Holds Steady Near 3742 as Support and Resistance Levels Remain Key KNSA Q1 2026 Earnings EPS Surges Past Estimates Despite Slight Stock Dip Globus Medical Inc GMED Q1 2026 Earnings Strong EPS Beat Drives Modest Share Gains Gladstone Land Corporation LAND Q1 2026 Earnings EPS Surprises to the Upside Despite Negative Bottom Line Contineum Therapeutics Inc CTNM Q1 2026 Earnings ClinicalStage Biotech Reports Narrower Loss Shares Dip SSSS Q1 2026 Earnings Massive EPS Surprise Driven by Portfolio Gains Annovis Bio Q1 2026 Earnings EPS Misses Estimates as PreClinical Spending Intensifies Live Oak Bancshares LOB Q1 2026 Earnings Strong EPS Beat as Net Interest Margins Hold Steady